Document:

General
RELEASE agreement

 

This General
Release Agreement (this “Agreement”), dated as of July 12, 2012, is entered into by and among BOLDFACE
Group, Inc., a Nevada corporation (“Seller”), BOLDFACE Split Corp., a Nevada corporation (“Split-Off Subsidiary”),
and Noah Levinson (“Buyer”). In consideration of the mutual benefits to be derived from this Agreement, the covenants
and agreements set forth herein, and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged
by the execution and delivery hereof, the parties hereto hereby agree as follows:

 

1.           Split-Off
Agreement. This Agreement is executed and delivered by Split-Off Subsidiary pursuant to the requirements of Section 8.3
of that certain Split-Off Agreement (the “Split-Off Agreement”) by and among Seller, Split-Off Subsidiary and Buyer
as a condition precedent to the closing (the “Closing”) of the Split-Off Agreement.

 

2.           Release
and Waiver by Split-Off Subsidiary. For and in consideration of the covenants and promises contained herein and in the
Split-Off Agreement, the receipt and sufficiency of which are hereby acknowledged, Split-Off Subsidiary, on behalf of itself and
its assigns, representatives and agents, if any, hereby covenants not to sue and fully, finally and forever completely releases
Seller, along with its present, future and former officers, directors, stockholders, members, employees, agents, attorneys and
representatives (collectively, the “Seller Released Parties”), of and from any and all claims, actions, obligations,
liabilities, demands and/or causes of action, of whatever kind or character, whether now known or unknown, which Split-Off Subsidiary
has or might claim to have against the Seller Released Parties for any and all injuries, harm, damages (actual and punitive), costs,
losses, expenses, attorneys’ fees and/or liability or other detriment, if any, whenever incurred or suffered by Split-Off
Subsidiary arising from, relating to, or in any way connected with, any fact, event, transaction, action or omission that occurred
or failed to occur on or prior to the date of the Closing.

 

3.           Release
and Waiver by Buyer. For and in consideration of the covenants and promises contained herein and in the Split-Off Agreement,
the receipt and sufficiency of which are hereby acknowledged, Buyer hereby covenants not to sue and fully, finally and forever
completely releases the Seller Released Parties of and from any and all claims, actions, obligations, liabilities, demands and/or
causes of action, of whatever kind or character, whether now known or unknown which Buyers have or might claim to have against
the Seller Released Parties for any and all injuries, harm, damages (actual and punitive), costs, losses, expenses, attorneys’
fees and/or liability or other detriment, if any, whenever incurred or suffered by Buyer arising from, relating to, or in any way
connected with, any fact, event, transaction, action or omission that occurred or failed to occur on or prior to the date of the
Closing.

 

4.           Additional
Covenants and Agreements.

 

(a)          Each
of Split-Off Subsidiary and Buyer, on the one hand, and Seller, on the other hand, waives and releases the other from any claims
that this Agreement was procured by fraud or signed under duress or coercion so as to make this Agreement not binding.

 

    	 

    	 

    

 

(b)          Each
of the parties hereto acknowledges and agrees that the releases set forth herein do not include any claims the other party hereto
may have against such party for such party’s failure to comply with or breach of any provision in this Agreement or the Split-Off
Agreement.

 

(c)          Notwithstanding
anything contained herein to the contrary, this Agreement shall not release or waive, or in any manner affect or void, any party’s
rights and obligations under the Split-Off Agreement.

 

5.           Modification.
This Agreement cannot be modified orally and can only be modified through a written document signed by both parties.

 

6.           Severability.
If any provision contained in this Agreement is determined to be void, illegal or unenforceable, in whole or in part, then
the other provisions contained herein shall remain in full force and effect as if the provision that was determined to be void,
illegal or unenforceable had not been contained herein.

 

7.           Expenses.
The parties hereto agree that each party shall pay its respective costs, including attorneys’ fees, if any, associated with
this Agreement.

 

8.           Further
Acts and Assurances. Split-Off Subsidiary and Buyer each agree that it will act in a manner supporting compliance, including
compliance by its Affiliates, with all of its obligations under this Agreement and, from time to time, shall, at the request of
Seller, and without further consideration, cause the execution and delivery of such other instruments of release or waiver and
take such other action or execute such other documents as such party may reasonably request in order to confirm or effect the releases,
waivers and covenants contained herein, and, in the case of any claims, actions, obligations, liabilities, demands and/or causes
of action that cannot be effectively released or waived without the consent or approval of other persons or entities that is unobtainable,
to use its best reasonable efforts to ensure that the Seller Released Parties receive the benefits thereof to the maximum extent
permissible in accordance with applicable law or other applicable restrictions, and shall perform such other acts which may be
reasonably necessary to effectuate the purposes of this Agreement. For the purposes of this Agreement, an “Affiliate”
is a person or entity that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under
common control with, another specified person or entity.

 

9.           Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving
effect to principles of conflicts or choice of laws thereof.

 

    	2

    	 

    

 

10.         Entire
Agreement. This Agreement constitutes the entire understanding and agreement of Seller, Split-Off Subsidiary and Buyer
and supersedes prior understandings and agreements, if any, among or between Seller, Split-Off Subsidiary and Buyer with respect
to the subject matter of this Agreement, other than as specifically referenced herein. This Agreement does not, however, operate
to supersede or extinguish any confidentiality, non-solicitation, non-disclosure or non-competition obligations owed by Split-Off
Subsidiary or Buyer to Seller under any prior agreement.

 

[Signature Page Follows]

 

    	3

    	 

    

 

IN WITNESS WHEREOF,
the undersigned have executed this General Release Agreement as of the day and year first above written.

 

	 	BOLDFACE GROUP, INC.
	 	 
	 	By:	/s/ Noah Levinson
	 	Name:  Noah Levinson
	 	Title: President
	 	 
	 	BOLDFACE SPLIT CORP.
	 	 
	 	By:	/s/ Noah Levinson
	 	Name:  Noah Levinson
	 	Title:  President
	 	 
	 	BUYER:
	 	 
	 	/s/ Noah Levinson
	 	Noah LevinsonSECURITIES PURCHASE AGREEMENT

 

THIS SECURITIES
PURCHASE AGREEMENT (this “Agreement”), is made effective as of July 12, 2012, and is entered into by and among
BOLDFACE Group, Inc. (formerly known as Max Cash Media, Inc.), a Nevada corporation (the “Company”), and the Buyer(s)
set forth on the signature pages affixed hereto (individually, a “Buyer” or collectively, the “Buyers”).

 

WITNESSETH:

 

WHEREAS, the
Company and the Buyer(s) are executing and delivering this Agreement in reliance upon an exemption from securities registration
pursuant to Section 4(2) and/or Rule 506 of Regulation D (“Regulation D”) and/or Regulation S (“Regulation
S”) as promulgated by the U.S. Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933,
as amended (the “Securities Act”); and

 

WHEREAS, the
parties desire that, upon the terms and subject to the conditions contained herein, the Company shall sell to the Buyers, as provided
herein, and the Buyers shall purchase in a private placement offering (the “PPO”), a minimum of 12,000,000 units (the
“Minimum PPO”) and a maximum of 20,000,000 units (the “Maximum PPO”) with an additional 3,000,000 units
subject to offer and sale pursuant to an over-allotment option, at a price of $0.25 per unit, with each PPO unit (the “Units”)
consisting of one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and one
redeemable five year common stock purchase warrant of the Company (the “PPO Warrant”) to purchase one share of Common
Stock at a price of $1.00 per share (the “PPO Warrant Shares”); and

 

WHEREAS, the
Company may offer the Units at any time through and including June 30, 2012, which date may be extended for an additional 30 days
(as such may be extended, the “Offering Period”) at the sole discretion of the Company and the Placement Agent (as
defined below); and

 

WHEREAS, prior
to the PPO, the Company sold an aggregate of $1,925,030 in principal amount of the Company’s 10% secured convertible promissory
notes (the “Bridge Notes”) in a bridge financing (the “Bridge Offering”); and

 

WHEREAS, the
Company is currently negotiating a reverse triangular merger (the “Merger”) with BOLDFACE Licensing + Branding, a Nevada
corporation (“BLB”), pursuant to which BLB will become a wholly owned subsidiary of the Company and the shareholders
of BLB will receive 20,000,000 shares of Common Stock; and

 

WHEREAS, the
PPO, in at least the Minimum PPO amount, shall close simultaneously with the closing of the Merger; and

 

WHEREAS, in
conjunction with the closing of the Merger and at least the Minimum PPO, the holders of the Bridge Notes shall receive 7,700,120
five-year warrants (the “Bridge Warrants”), each to purchase one share of Common Stock, 3,850,060 of which Bridge Warrants
are exercisable at $0.25 per share and 3,850,060 of which Bridge Warrants are exercisable at $0.50 per share; and

 

    	 

    	 

    

 

WHEREAS, the
conversion of the principal amount of the Bridge Notes into PPO Units will count towards the achievement of the Minimum PPO; and

 

WHEREAS, the
principal amount of the Bridge Notes, simultaneously upon the closing of the Merger and at least the Minimum PPO amount, shall
be converted into Units at a price of $0.25 per Unit; and

 

WHEREAS, the
total principal amount of the Bridge Notes, subject to the deduction of applicable fees and expenses, was utilized by the Company
to make a loan (the “Bridge Loan”) to BLB; and

 

WHEREAS, $1,000,000
of the Bridge Loan proceeds were used by BLB to timely meet its obligations under the May 9, 2012 Licensing Agreement (the “BLB
Licensing Agreement”) by and among BLB, on one hand, and 2Die4Kourt, Inc., Kimsaprincess, Inc. and Khloemoney, Inc. (collectively,
the “Licensors”), on the other hand, to pay a $1,000,000 advance to the Licensors; and

 

WHEREAS, pursuant
to the Licensing Agreement, the Licensors (taken as a whole) will receive, at their discretion, either 10,000,000 shares of the
Company’s restricted Common Stock or ten year warrants to purchase 10,000,000 shares of the Company’s Common Stock,
each warrant exercisable at a price equal to the fair market value of the Company’s Common Stock at the time of warrant issuance
(the “Talent Issuance”); and

 

WHEREAS, the
BLB shareholders shall receive post-Merger (i) an additional 5,000,000 shares of the Company’s Common Stock or, at their
option, ten year warrants to purchase an additional 5,000,000 shares of the Company’s Common Stock, exercisable at $0.25
per share upon BLB closing a second licensing agreement; and (ii) an additional 2,500,000 ten year warrants to purchase up to an
additional 2,500,000 shares of the Company’s Common Stock at a price equal to the lesser of (a) the fair market value of
the Company’s Common Stock at the time of warrant issuance, or (b) if applicable, the price at which the Company’s
Common Stock is being sold in an offering taking place at the time of warrant issuance, upon BLB closing a third licensing agreement;
and

 

WHEREAS, the
Bridge Warrants, Placement Agent Warrants (as defined below), PPO Warrants, and the Common Stock comprising part of the Units will
have weighted average anti-dilution price protection, subject to customary exceptions, if within two years after the closing of
the Merger, the Company issues additional shares of Common Stock or Common Stock equivalents for a consideration per share less
than the PPO Offering price of $0.25 per Unit, as such PPO Offering price may be adjusted; and

 

WHEREAS, prior
to or upon the closing of the Merger and at least the Minimum PPO amount, the Company shall have adopted a 20,000,000 share Equity
Incentive Plan for the future issuance of awards to officers, directors, key employees and consultants of the Company; and

 

    	2

    	 

    

 

WHEREAS, in
anticipation of the Merger and the PPO, the Company (i) changed its name to BOLDFACE Group, Inc. and (ii) conducted a forward stock
split in the form of a stock dividend in the ratio of approximately 37.9562:1 (the “Forward Split”); and;

 

WHEREAS, simultaneously
with the closing of the Merger and the PPO, if any, the Company will transfer all of its pre-Merger operating assets and liabilities
to a newly formed wholly owned subsidiary (“Split-Off Subsidiary”), and thereafter, the Company shall transfer all
of the outstanding shares of capital stock of Split-Off Subsidiary to the Company’s pre-Merger insider in exchange for the
surrender and cancellation of shares of Common Stock held by such insider (the “Split-Off”) (the Merger, the PPO, the
Forward Split, the Split-Off, the Talent Issuance, and the transactions contemplated thereby are sometimes hereinafter referred
to as the “Transactions”); and

 

WHEREAS, all
of the Transactions give retroactive effect to the Forward Split such that the number of Company securities to be issued in connection
with the PPO, the exercise of the Bridge Warrants, the number of Company securities to be issued pursuant to the Talent Issuance,
and all other issuances of Company securities contemplated by this Agreement, will not be effected by the effectuation of the Forward
Split; and

 

WHEREAS, Gottbetter
Capital Markets, LLC (the “Placement Agent”), a FINRA registered broker-dealer, acted as the Company’s Placement
Agent on a best efforts basis, in connection with the Bridge Offering and will act as the Company’s Placement Agent on a
best efforts basis in the PPO; and

 

WHEREAS, with
respect to the Bridge Offering, the Placement Agent was paid a cash commission of 4% of funds raised from Buyers introduced to
the Bridge Offering by it, provided that, upon the conversion of the Bridge Notes upon the closing of the Merger and at least the
Minimum PPO, the Placement Agent will be paid an additional 4% of funds raised from Buyers introduced to the Bridge Offering by
it, plus a warrant commission in the form of a Placement Agent warrant (the “Placement Agent Warrant”) to purchase
such number of shares of the Company’s Common Stock as is equal to 8% of the number of PPO Units into which the Bridge Notes
sold to Buyers introduced to the Bridge Offering by it are converted with each Placement Agent Warrant having a term of 5 years
and an exercise price of $0.25 per share; and

 

WHEREAS, with
respect to the PPO, the Placement Agent will be paid a cash commission of 8% of funds raised from the Buyers introduced to the
PPO by it plus a warrant commission in the form of a Placement Agent Warrant identical to the Placement Agent Warrant to be issued
to the Placement Agent with respect to the Bridge Note conversions, to purchase such number of shares of the Company’s Common
Stock as is equal to 8% of the number of Units sold to Buyers introduced to the PPO by it having a term of 5 years and an exercise
price of $0.25 per share; and

 

WHEREAS, the
aggregate proceeds from the sale of the Units shall be held in escrow pursuant to the terms of an escrow agreement substantially
in the form of Exhibit A to this Agreement among the Company and the Escrow Agent (as defined below) (the “Escrow
Agreement”).

 

    	3

    	 

    

 

WHEREAS, promptly,
but no later than ninety calendar days from the closing date of the PPO, the Company shall file a registration statement on Form
S-1, or similar form with the SEC covering (i) shares of Common Stock underlying the Bridge Warrants; (ii) the shares of Common
Stock comprising part of the PPO Units; and (iii) the shares of Common Stock underlying the PPO Warrants.

 

NOW, THEREFORE,
in consideration of the mutual covenants and other agreements contained in this Agreement the Company and the Buyer(s) hereby agree
as follows:

 

1.           PURCHASE
AND SALE OF UNITS.

 

(a)          Purchase
of Units. Subject to the satisfaction (or waiver) of the terms and conditions of this Agreement, each Buyer agrees, severally
and not jointly, to purchase at Closing (as defined below), and the Company agrees to sell and issue to each Buyer, severally and
not jointly, at Closing, Units in the amounts set forth on the Buyer Omnibus Signature Page, attached hereto as Annex A, for each
Buyer affixed hereto. The PPO Warrants comprising part of the Units shall be substantially in the form attached as Exhibit B
to this Agreement. Upon execution of this Agreement on the Buyer Omnibus Signature Page and completion of the Investor Certification,
the Investor Profile, the Anti-Money Laundering Information Form and if applicable, the Wire Transfer Authorization (each attached
hereto) by a Buyer, the Buyer shall wire transfer the Subscription Amount set forth on its Buyer Omnibus Signature Page, in same-day
funds in accordance with the instructions set forth immediately below, which Subscription Amount shall be held in escrow pursuant
to the terms of the Escrow Agreement and disbursed in accordance therewith.

 

Wire Instructions

 

	Bank Name:	PNC Bank
		300 Delaware Avenue 
		Wilmington, DE 19899 
	ABA Routing Number:	031100089
	Account Name:	CSC Trust Company of Delaware
	Account Number:	5605012373
	Reference:	BOLDFACE Group, Inc.; 79-1743; [insert Buyer’s name]
	Escrow Agent Contact:	Alan R. Halpern

 

(b)          Closing
Date. The initial closing of the purchase and sale of the Units (the “Closing”) shall take place at 10:00 a.m.
New York time on or before the 3rd business day following the satisfaction of the conditions to the Closing set forth
herein and in Sections 7 and 8 below (or such later date as is mutually agreed to by the Company and the Buyer(s)). There may be
multiple Closings, subject to prior termination, until such time as subscriptions for the Maximum Amount are accepted (the date
of any such Closing is hereinafter referred to as a “Closing Date”). The Closing shall occur on the Closing Date at
the offices of Gottbetter & Partners, LLP, 488 Madison Avenue, New York, New York 10022 (or such other place as is mutually
agreed to by the Company and the Buyer(s)). The Units may be offered and sold through the end of the Offering Period.

 

    	4

    	 

    

 

(c)          Escrow
Arrangements; Form of Payment. Upon execution hereof by the Buyer and pending the Closing, the Purchase Price shall be deposited
in a non-interest bearing escrow account with CSC Trust Company of Delaware, as escrow agent (the “Escrow Agent”),
pursuant to the terms of the Escrow Agreement. Subject to the satisfaction of the terms and conditions of this Agreement, on the
Closing Date or as soon as practicable thereafter, (i) the Escrow Agent shall deliver to the Company in accordance with the terms
of the Escrow Agreement the Purchase Price for the Units to be issued and sold to the Buyer(s) on such Closing Date, and (ii) the
Company shall deliver to the Buyer(s), the certificates for the Common Stock and the PPO Warrants, duly executed on behalf of the
Company.

 

(d)          Brokers
or their sub-agents who introduce to the Company Buyers may be paid a commission in amounts and on terms as indicated in the placement
agency agreement to be entered into between the Company and such brokers (collectively, the “Brokers’ Fees”).

 

2.           BUYER’S
REPRESENTATIONS AND WARRANTIES.

 

Each Buyer represents
and warrants, severally and not jointly, as to such Buyer, that:

 

(a)          Investment
Purpose. Each Buyer is acquiring the Units, including the Common Stock, PPO Warrants and PPO Warrant Shares, for its own account
for investment only and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except
pursuant to sales registered or exempted under the Securities Act; provided, however, that by making the representations herein,
such Buyer reserves the right to dispose of the Common Stock comprising part of the Units and the Common Stock underlying the PPO
Warrants at any time in accordance with or pursuant to an effective registration statement covering such Common Stock, or an available
exemption under the Securities Act. The Buyer agrees not to sell, hypothecate or otherwise transfer the Buyer’s securities
unless such securities are registered under the federal and applicable state securities laws or unless, in the opinion of counsel
satisfactory to the Company, an exemption from such law is available. Each Buyer understands and agrees that the Company, in its
sole discretion, reserves the right to accept or reject subscriptions for Units in whole or in part.

 

(b)          Residence
of Buyer. Each Buyer resides in the jurisdiction set forth on the Buyer Omnibus Signature Page affixed hereto.

 

(c)          Investor
Status. The Buyer meets the requirements of at least one of the suitability standards for an “Accredited Investor”
as that term is defined in Rule 501(a)(3) of Regulation D or is not a “U.S. Person” as that term is defined
in Rule 902(k) of Regulation S, and as set forth on the Investor Certification attached hereto.

 

(d)          Non-US
Person. If a Buyer is not a person in the United States or a U.S. Person (as defined in Rule 902(k) of Regulation S) or is
not purchasing the Units on behalf of a person in the United States or a U.S. Person:

 

(i)          neither
the Buyer nor any disclosed principal is a U.S. Person nor are they subscribing for the Units for the account of a U.S. Person
or for resale in the United States and the Buyer confirms that the Units have not been offered to the Buyer in the United States
and that this Agreement has not been signed in the United States;

 

    	5

    	 

    

 

(ii)         the
Buyer acknowledges that the Units have not been registered under the Securities Act and may not be offered or sold in the United
States or to a U.S. Person unless the securities are registered under the U.S. Securities Act and all applicable state securities
laws or an exemption from such registration requirements is available, and further agrees that hedging transactions involving such
securities may not be conducted unless in compliance with the U.S. Securities Act;

 

(iii)        the
Buyer and if applicable, the disclosed principal for whom the Buyer is acting, understands that the Company is the seller of the
Units and underlying securities and that, for purposes of Regulation S, a “distributor” is any underwriter, dealer
or other person who participates pursuant to a contractual arrangement in the distribution of securities sold in reliance on Regulation
S and that an “affiliate” is any partner, officer, director or any person directly or indirectly controlling, controlled
by or under common control with any person in question. Except as otherwise permitted by Regulation S, the Buyer and if applicable,
the disclosed principal for whom the Buyer is acting, agrees that it will not, during a one year distribution compliance period,
act as a distributor, either directly or through any affiliate, or sell, transfer, hypothecate or otherwise convey the Units or
underlying securities other than to a non-U.S. Person;

 

(iv)        the
Buyer and if applicable, the disclosed principal for whom the Buyer is acting, acknowledges and understands that in the event the
Units are offered, sold or otherwise transferred by the Buyer or if applicable, the disclosed principal for whom the Buyer is acting,
to a non-U.S Person prior to the expiration of a one year distribution compliance period, the purchaser or transferee must agree
not to resell such securities except in accordance with the provisions of Regulation S, pursuant to registration under the Securities
Act, or pursuant to an available exemption from registration; and must further agree not to engage in hedging transactions with
regard to such securities unless in compliance with the Securities Act; and

 

(v)         neither
the Buyer nor any disclosed principal will offer, sell or otherwise dispose of the Units or the underlying securities in the United
States or to a U.S. Person unless (A) the Company has consented to such offer, sale or disposition and such offer, sale or disposition
is made in accordance with an exemption from the registration requirements under the Securities Act and the securities laws of
all applicable states of the United States or, (B) the SEC has declared effective a registration statement in respect of such securities.

 

(e)          Investor
Qualifications. The Buyer (i) if a natural person, represents that the Buyer has reached the age of 21 and has full power and
authority to execute and deliver this Agreement and all other related agreements or certificates and to carry out the provisions
hereof and thereof; (ii) if a corporation, partnership, or limited liability company or partnership, or association, joint stock
company, trust, unincorporated organization or other entity, represents that such entity was not formed for the specific purpose
of acquiring the Units, such entity is duly organized, validly existing and in good standing under the laws of the state of its
organization, the consummation of the transactions contemplated hereby is authorized by, and will not result in a violation of
state law or its charter or other organizational documents, such entity has full power and authority to execute and deliver this
Agreement and all other related agreements or certificates and to carry out the provisions hereof and thereof and to purchase and
hold the Units, the execution and delivery of this Agreement has been duly authorized by all necessary action, this Agreement has
been duly executed and delivered on behalf of such entity and is a legal, valid and binding obligation of such entity; or (iii)
if executing this Agreement in a representative or fiduciary capacity, represents that it has full power and authority to execute
and deliver this Agreement in such capacity and on behalf of the subscribing individual, ward, partnership, trust, estate, corporation,
or limited liability company or partnership, or other entity for whom the Buyer is executing this Agreement, and such individual,
partnership, ward, trust, estate, corporation, or limited liability company or partnership, or other entity has full right and
power to perform pursuant to this Agreement and make an investment in the Company, and represents that this Agreement constitutes
a legal, valid and binding obligation of such entity. The execution and delivery of this Agreement will not violate or be in conflict
with any order, judgment, injunction, agreement or controlling document to which the Buyer is a party or by which it is bound.

 

    	6

    	 

    

 

(f)          Buyer
Relationship with Brokers The Buyer’s substantive relationship with any broker for the transactions contemplated hereby
or subagent thereof (collectively, “Brokers”) through which the Buyer is subscribing for the Units predates such Broker’s
contact with the Buyer regarding an investment in the Units.

 

(g)          Solicitation.
The Buyer is unaware of, is in no way relying on, and did not become aware of the offering of the Units through or as a result
of, any form of general solicitation or general advertising including, without limitation, any article, notice, advertisement or
other communication published in any newspaper, magazine or similar media or broadcast over television or radio, in connection
with the offering and sale of the Units and is not subscribing for the Units and did not become aware of the offering of the Units
through or as a result of any seminar or meeting to which the Buyer was invited by, or any solicitation of a subscription by, a
person not previously known to the Buyer in connection with investments in securities generally.

 

(h)          Brokerage
Fees. The Buyer has taken no action that would give rise to any claim by any person for brokerage commissions, finders’
fees or the like relating to this Agreement or the transaction contemplated hereby (other than commissions to be paid by the Company
to the Brokers, as described above).

 

(i)           Buyer’s
Advisors. The Buyer and the Buyer’s attorney, accountant, purchaser representative and/or tax advisor, if any (collectively,
the “Advisors”), as the case may be, has such knowledge and experience in financial, tax, and business matters, and,
in particular, investments in securities, so as to enable it to utilize the information made available to it in connection with
the Units to evaluate the merits and risks of an investment in the Units and the Company and to make an informed investment decision
with respect thereto.

 

(j)           Buyer
Liquidity. Each Buyer has adequate means of providing for such Buyer’s current financial needs and foreseeable contingencies
and has no need for liquidity of its investment in the Units for an indefinite period of time.

 

(k)          High
Risk Investment; Review of Risk Factors. The Buyer is aware that an investment in the Units involves a number of very significant
risks, including those set forth in Exhibit D, hereto and has carefully reviewed and understands the risks of, and other considerations
relating to, the purchase of the Unit, including the underlying securities.

 

    	7

    	 

    

 

(l)          Reliance
on Exemptions. Each Buyer understands that the Units are being offered and sold to it in reliance on specific exemptions from
the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the
truth and accuracy of, and such Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and
understandings of such Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of
such Buyer to acquire such securities.

 

(m)         Information.
Each Buyer and its Advisors have been furnished with all documents and materials relating to the business, finances and operations
of the Company and information that Buyer requested and deemed material to making an informed investment decision regarding its
purchase of the Units and the underlying securities. Each Buyer and its Advisors have been afforded the opportunity to review such
documents and materials, as well as the Company’s SEC Filings, as such term is defined below (hard copies of which were made
available to the Buyer upon request to the Company or were otherwise accessible to the Buyer via the SEC’s EDGAR system),
and the information contained therein. Each Buyer and its Advisors have been afforded the opportunity to ask questions of the Company
and its management. Each Buyer understands that such discussions, as well as any written information provided by the Company, were
intended to describe the aspects of the Company’s business and prospects which the Company believes to be material, but were
not necessarily a thorough or exhaustive description, and except as expressly set forth in this Agreement, the Company makes no
representation or warranty with respect to the completeness of such information and makes no representation or warranty of any
kind with respect to any information provided by any entity other than the Company. Some of such information may include projections
as to the future performance of the Company, which projections may not be realized, may be based on assumptions which may not be
correct and may be subject to numerous factors both beyond and within the Company’s control. Additionally, the Subscriber
understands and represents that he is purchasing the Units notwithstanding the fact that the Company may disclose in the future
certain material information the Subscriber has not received, including its financial results for its current fiscal quarter. Neither
such inquiries nor any other due diligence investigations conducted by such Buyer or its Advisors shall modify, amend or affect
such Buyer’s right to rely on the Company’s representations and warranties contained in Section 3 below. Each Buyer
has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect
to its acquisition of the Units.

 

(n)          No
Other Representations or Information. In evaluating the suitability of an investment in the Units, the Buyer has not relied
upon any representation or information (oral or written) other than as stated in this Agreement. No oral or written representations
have been made, or oral or written information furnished, to the Buyer or its Advisors, if any, in connection with the offering
of the Units.

 

(o)          No
Governmental Review. Each Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Units (or the underlying securities), or the fairness or
suitability of the investment in the Units (and the underlying securities), nor have such authorities passed upon or endorsed the
merits of the offering of the Units.

 

    	8

    	 

    

 

(p)          Transfer
or Resale. (A) Each Buyer understands that: (i) the Units, including the underlying securities, have not been and are not being
registered under the Securities Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred
unless (A) subsequently registered thereunder, or (B) such Buyer shall have delivered to the Company an opinion of counsel, in
a generally acceptable form, to the effect that such securities to be sold, assigned or transferred may be sold, assigned or transferred
pursuant to an exemption from such registration requirements; (ii) any sale of such securities made in reliance on Rule 144 under
the Securities Act (or a successor rule thereto) (“Rule 144”) may be made only in accordance with
the terms of Rule 144 and further, if Rule 144 is not applicable, any resale of such securities under circumstances in which the
seller (or the person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the Securities
Act) may require compliance with some other exemption under the Securities Act or the rules and regulations of the SEC thereunder;
and (iii) except as otherwise set forth in this Agreement and the Registration Rights Agreement (substantially in the form attached
as Exhibit C), neither the Company nor any other person is under any obligation to register such securities under the Securities
Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder. The Company reserves the
right to place stop transfer instructions against the shares and certificates for the Common Stock comprising part of the Units
and the Warrant Shares underlying the PPO Warrant to the extent specifically set forth under this Agreement. There can be no assurance
that there will be any market or resale for the Units (or the Common Stock, including the Common Stock
underlying the Units and the PPO Warrants), nor can there be any assurance that the Units (or the Common Stock, including
the Common Stock underlying the Units and PPO Warrants) will be freely transferable at any time in the foreseeable future.

 

(B)     Each Buyer
understands that the Company is currently a “shell company” as defined in Rule 12b-2 under the Securities Exchange
Act of 1934, as amended (the “Exchange Act”).  Pursuant to Rule 144(i), securities issued by a current or former
shell company (that is, the Units (and the underlying securities)) that otherwise meet the holding period and other requirements
of Rule 144 nevertheless cannot be sold in reliance on Rule 144 until one year after the Company (a) is no longer a shell company;
and (b) has filed current “Form 10 information” (as defined in Rule 144(i)) with the SEC reflecting that it is no longer
a shell company, and provided that at the time of a proposed sale pursuant to Rule 144, the Company is subject to the reporting
requirements of section 13 or 15(d) of the Exchange Act and has filed all reports and other materials required to be filed by section
13 or 15(d) of the Exchange Act, as applicable, during the preceding 12 months (or for such shorter period that the issuer was
required to file such reports and materials), other than Form 8-K reports.  As a result, the restrictive legends on certificates
for the Securities cannot be removed except in connection with an actual sale meeting the foregoing requirements or pursuant to
an effective registration statement.

 

(q)          Legends.
Each Buyer understands that the certificates or other instruments representing the Units and PPO Warrants (and the Common Stock
underlying the Units and PPO Warrants) shall bear a restrictive legend in substantially the following form (and a stop transfer
order may be placed against transfer of such stock certificates):

 

    	9

    	 

    

 

For U.S.
Persons:

 

THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
THESE SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE COMPANY, (B) OUTSIDE THE UNITED STATES
IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, (C) IN COMPLIANCE WITH RULE 144 OR 144A THEREUNDER, IF AVAILABLE,
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, (D) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT, OR (E) IN A TRANSACTION
THAT DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS, AND THE HOLDER HAS, PRIOR
TO SUCH SALE, FURNISHED TO THE COMPANY AN OPINION OF COUNSEL OR OTHER EVIDENCE OF EXEMPTION, IN EITHER CASE REASONABLY SATISFACTORY
TO THE COMPANY. HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

 

For Non-U.S.
Persons:

 

THESE SECURITIES WERE ISSUED
IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S) PURSUANT TO REGULATION S UNDER THE
UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”). ACCORDINGLY, NONE OF THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE
MAY BE OFFERED OR SOLD IN THE UNITED STATES OR, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT OR PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT,
AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES
MAY NOT BE CONDUCTED UNLESS IN ACCORDANCE WITH THE 1933 ACT.

 

    	10

    	 

    

 

The legend set forth above shall be removed
and the Company within three (3) business days shall issue a certificate without such legend to the holder of the Units and the
PPO Warrants (and the Common Stock underlying the PPO Units and PPO Warrants,) upon which it is stamped, if, unless otherwise required
by state securities laws, (i) the Buyer or its broker make the necessary representations and warranties to the transfer agent for
the Common Stock that it has complied with the prospectus delivery requirements in connection with a sale transaction, provided
the Units and PPO Warrants (and the Common Stock underlying the Units and PPO Warrants) are registered under the Securities Act
or (ii) in connection with a sale transaction, after such holder provides the Company with an opinion of counsel satisfactory to
the Company, which opinion shall be in form, substance and scope customary for opinions of counsel in comparable transactions,
to the effect that a public sale, assignment or transfer of the Units or PPO Warrants (or the Common Stock underlying the Units
and PPO Warrants) may be made without registration under the Securities Act.

 

(r)          Authorization,
Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of such Buyer and is a valid
and binding agreement of such Buyer enforceable in accordance with its terms, except as such enforceability may be limited by general
principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating
to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

(s)          Receipt
of Documents. Each Buyer and its counsel have received and read in their entirety: (i) this Agreement, the Risk Factors applicable
to an investment in the Units as set forth in Exhibit F, and each representation, warranty and covenant set forth herein; and (ii)
all due diligence and other information necessary to verify the accuracy and completeness of such representations, warranties and
covenants; each Buyer has received answers to all questions such Buyer submitted to the Company regarding an investment in the
Company; and each Buyer has relied on the information contained therein and has not been furnished any other documents, literature,
memorandum or prospectus.

 

(t)          Trading
Activities. The Buyer’s trading activities with respect to the Company’s Common Stock shall be in compliance with
all applicable federal and state securities laws, rules and regulations and the rules and regulations of the principal market on
which the Company’s Common Stock is listed or traded. Neither the Buyer nor its affiliates has an open short position in
the Common Stock of the Company and, except as set forth below, the Buyer shall not, and shall not cause any of its affiliates
under common control with the Buyer, to engage in any short sale as defined in any applicable SEC or Financial Industry Regulatory
Authority (FINRA) rules on any hedging transactions with respect to the Common Stock until the earlier to occur of (i) the second
anniversary of the Closing Date and (ii) the Buyer(s) no longer own Common Stock. Without limiting the foregoing, the Buyer agrees
not to engage in any naked short transactions in excess of the amount of shares owned (or an offsetting long position) by the Buyer.

 

    	11

    	 

    

 

(u)          Regulation
FD. Each Buyer acknowledges and agrees that all of the information received by it in connection with the transactions contemplated
by this Agreement and the other Transactions is of a confidential nature and may be regarded as material non-public information
under Regulation FD promulgated by the SEC and that such information has been furnished to the Buyer for the sole purpose of enabling
the Buyer to consider and evaluate an investment in the Units. The Buyer agrees that it will treat such information in a confidential
manner, will not use such information for any purpose other than evaluating an investment in the Units, will not, directly or indirectly,
trade or permit the Buyer’s agents, representatives or affiliates to trade in any securities of the Company while in possession
of such information and will not, directly or indirectly, disclose or permit the Buyer’s agents, representatives or affiliates
to disclose any of such information without the Company’s prior written consent. The Buyer shall make its agents, affiliates
and representatives aware of the confidential nature of the information contained herein and the terms of this section including
the Buyer’s agreement to not disclose such information, to not trade in the Company’s securities while in the possession
of such information and to be responsible for any disclosure or other improper use of such information by such agents, affiliates
or representatives. Likewise, without the Company’s prior written consent, the Buyer will not, directly or indirectly, make
any statements, public announcements or other release or provision of information in any form to any trade publication, to the
press or to any other person or entity whose primary business is or includes the publication or dissemination of information related
to the transactions contemplated by this Agreement. In the event the Merger (or other business combination if such transaction
assumes a different corporate form) is not entered into, the Company acknowledges that the information covered by this Section
2(u) will no longer be deemed material, non public information under Regulation FD.

 

(v)         No
Legal Advice from the Company. Each Buyer acknowledges that it had the opportunity to review this Agreement and the transactions
contemplated by this Agreement with its own legal counsel and investment and tax advisors. Each Buyer is relying solely on such
Advisors and not on any statements or representations of the Company or any of its representatives or agents for legal, tax or
investment advice with respect to this investment, the transactions contemplated by this Agreement or the securities laws of any
jurisdiction.

 

(w)          No
Group Participation. Each Buyer and its affiliates is not a member of any group, nor is any Buyer acting in concert with any
other person, including any other Buyer, with respect to its acquisition of the Units, including the PPO Warrants (and the Common
Stock, including the Common Stock underlying the Units and PPO Warrants).

 

(x)          Reliance.
Any information which the Buyer has heretofore furnished or is furnishing herewith to the Company or any Broker is complete and
accurate and may be relied upon by the Company and any Broker in determining the availability of an exemption from registration
under federal and state securities laws in connection with the offering of securities as described in the Transmittal Letter. The
Buyer further represents and warrants that it will notify and supply corrective information to the Company immediately upon the
occurrence of any change therein occurring prior to the Company’s issuance of the securities comprising part of the Units.
Within five (5) days after receipt of a request from the Company or any Broker, the Buyer will provide such information and deliver
such documents as may reasonably be necessary to comply with any and all laws and ordinances to which the Company or any Broker
is subject.

 

(y)          (For
ERISA plan Buyers only). The fiduciary of the ERISA plan represents that such fiduciary has been informed of and understands
the Company’s investment objectives, policies and strategies, and that the decision to invest “plan assets” (as
such term is defined in ERISA) in the Company is consistent with the provisions of ERISA that require diversification of plan assets
and impose other fiduciary responsibilities. The Buyer fiduciary or Plan (a) is responsible for the decision to invest in the Company;
(b) is independent of the Company or any of its affiliates; (c) is qualified to make such investment decision; and (d) in making
such decision, the Buyer fiduciary or Plan has not relied primarily on any advice or recommendation of the Company or any of its
affiliates;

 

    	12

    	 

    

 

(z)          [The
Buyer should check the Office of Foreign Assets Control (“OFAC”) website at http://www.treas.gov/ofac before making
the following representations.] The Buyer represents that the amounts invested by it in the Company in the Units were not and
are not directly or indirectly derived from activities that contravene federal, state or international laws and regulations, including
anti-money laundering laws and regulations. Federal regulations and Executive Orders administered by OFAC prohibit, among other
things, the engagement in transactions with, and the provision of services to, certain foreign countries, territories, entities
and individuals. The lists of OFAC prohibited countries, territories, persons and entities can be found on the OFAC website at
http://www.treas.gov/ofac. In addition, the programs administered by OFAC (the “OFAC Programs”) prohibit dealing with
individuals1 or entities in certain countries regardless of whether such individuals or entities appear on the OFAC
lists;

 

(aa)         To
the best of the Buyer’s knowledge, none of: (1) the Buyer; (2) any person controlling or controlled by the Buyer; (3) if
the Buyer is a privately-held entity, any person having a beneficial interest in the Buyer; or (4) any person for whom the Buyer
is acting as agent or nominee in connection with this investment is a country, territory, individual or entity named on an OFAC
list, or a person or entity prohibited under the OFAC Programs. Please be advised that the Company may not accept any amounts from
a prospective investor if such prospective investor cannot make the representation set forth in the preceding paragraph. The Buyer
agrees to promptly notify the Company should the Buyer become aware of any change in the information set forth in these representations.
The Buyer understands and acknowledges that, by law, the Company may be obligated to “freeze the account” of the Buyer,
either by prohibiting additional subscriptions from the Buyer, declining any redemption requests and/or segregating the assets
in the account in compliance with governmental regulations, and a Broker may also be required to report such action and to disclose
the Buyer’s identity to OFAC. The Buyer further acknowledges that the Company may, by written notice to the Buyer, suspend
the redemption rights, if any, of the Buyer if the Company reasonably deems it necessary to do so to comply with anti-money laundering
regulations applicable to the Company or any Broker or any of the Company’s other service providers. These individuals include
specially designated nationals, specially designated narcotics traffickers and other parties subject to OFAC sanctions and embargo
programs;

 

(bb)         To
the best of the Buyer’s knowledge, none of: (1) the Buyer; (2) any person controlling or controlled by the Buyer; (3) if
the Buyer is a privately-held entity, any person having a beneficial interest in the Buyer; or (4) any person for whom the Buyer
is acting as agent or nominee in connection with this investment is a senior foreign political figure2, or
any immediate family3 member or close associate4 of a senior foreign political figure, as such
terms are defined in the footnotes below; and

 

 

		1	These individuals include specially designated nationals, specially
designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs.

 

		2	A “senior foreign political figure” is defined as a senior
official in the executive, legislative, administrative, military or judicial branches of a foreign government (whether elected
or not), a senior official of a major foreign political party, or a senior executive of a foreign government-owned corporation.
In addition, a “senior foreign political figure” includes any corporation, business or other entity that has been formed
by, or for the benefit of, a senior foreign political figure.

 

		3	“Immediate family” of a senior foreign political figure
typically includes the figure’s parents, siblings, spouse, children and in-laws.

 

		4	A “close associate” of a senior foreign political figure
is a person who is widely and publicly known to maintain an unusually close relationship with the senior foreign political figure,
and includes a person who is in a position to conduct substantial domestic and international financial transactions on behalf of
the senior foreign political figure.

 

    	13

    	 

    

 

(cc)         If
the Buyer is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Buyer receives deposits from,
makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Buyer represents and warrants
to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a country in which the
Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related to its banking
activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank to conduct banking
activities; and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that does not have a physical
presence in any country and that is not a regulated affiliate.

 

3.           REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.

 

The Company represents
and warrants to each of the Buyers that:

 

(a)          Organization
and Qualification. The Company is a corporation duly organized and validly existing in good standing under the laws of the
State of Nevada, and has the requisite corporate power to own its properties and to carry on its business as now being conducted.
The Company is duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which the
nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified
or be in good standing would not have a Material Adverse Effect, as defined below. The Company has no subsidiaries.

 

(b)          Authorization,
Enforcement, Compliance with Other Instruments. (i) The Company has the requisite corporate power and authority to enter
into and perform this Agreement, the Registration Rights Agreement, the Escrow Agreement and all other documents necessary or desirable
to effect the transactions contemplated hereby (collectively the “Transaction Documents”) to which it is a party and
to issue the Units, including the PPO Warrants (and the Common Stock, including the Common Stock underlying the Units and the PPO
Warrants) in accordance with the terms hereof and thereof, (ii) the execution and delivery of the Transaction Documents by the
Company and the consummation by it of the transactions contemplated hereby and thereby, including, without limitation, the issuance
of the Units (and the Common Stock, including the Common Stock underlying the Units and PPO Warrants)
and the reservation for issuance of the PPO Warrant Shares have been duly authorized by the Company’s Board of Directors
and no further consent or authorization is required by the Company, its Board of Directors or its stockholders, (iii) the Transaction
Documents will be duly executed and delivered by the Company, (iv) the Transaction Documents when executed will constitute the
valid and binding obligations of the Company enforceable against the Company in accordance with their terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of creditors’ rights and remedies.

 

    	14

    	 

    

 

(c)          Capitalization.
The authorized capital stock of the Company consists of 300,000,000 shares of Common Stock and 10,000,000 shares of blank check
preferred stock, $0.001 par value per share (“Preferred Stock”). As of the date hereof, the Company has 6,370,000 pre-split
shares of Common Stock issued and outstanding (of which it is anticipated that 5,000,000 pre-split shares will be surrendered and
retired in connection with the Split-Off) and no shares of Preferred Stock outstanding. All of such outstanding shares have been
duly authorized, validly issued and are fully paid and nonassessable. No shares of Common Stock are subject to preemptive rights
or any other similar rights or any liens or encumbrances suffered or permitted by the Company. As of June 1, 2012 and except as
issued in the Bridge Offering or as set forth on Schedule 3(c) or as contemplated by the Merger or PPO, (i) there are no outstanding
options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or
rights convertible into, any shares of capital stock of the Company, or contracts, commitments, understandings or arrangements
by which the Company is or may become bound to issue additional shares of capital stock of the Company or options, warrants, scrip,
rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into,
any shares of capital stock of the Company, (ii) there are no outstanding debt securities and (iii) there are no agreements or
arrangements under which the Company is obligated to register the sale of any of their securities under the Securities Act (except
in connection with the Merger and the PPO), and (iv) there are no outstanding registration statements and there are no outstanding
comment letters from the SEC or any other regulatory agency. There are no securities or instruments containing anti-dilution or
similar provisions that will be triggered by the issuance of the Units as described in this Agreement. The Units, including the
PPO Warrants (and the Common Stock underlying the Units and PPO Warrants) when issued, will be
free and clear of all pledges, liens, encumbrances and other restrictions (other than those arising under federal or state securities
laws as a result of the issuance of the Unit and the underlying securities). No co-sale right, right of first refusal or other
similar right exists with respect to the Units (or the Common Stock underlying the Units and PPO Warrants) or the issuance and
sale thereof. The issue and sale of the Units (and the Common Stock underlying the Units and PPO Warrants) will not result in a
right of any holder of Company securities to adjust the exercise, exchange or reset price under such securities. The Company has
made available to the Buyer true and correct copies of the Company’s Articles of Incorporation, and as in effect on the date
hereof (the “Articles of Incorporation”), and the Company’s By-laws, as in effect on the date hereof (the “By-laws”),
and the terms of all securities exercisable for Common Stock and the material rights of the holders thereof in respect thereto
other than stock options issued to employees and consultants.

 

(d)          Issuance
of Securities. The Units are duly authorized and, upon issuance in accordance with the terms hereof, shall be duly issued,
fully paid and nonassessable, are free from all taxes, liens and charges with respect to the issue thereof. The Common
Stock underlying the Units and PPO Warrants has been duly authorized and reserved for issuance. Upon issuance, the Common
Stock underlying the Units and PPO Warrants will be duly issued, fully paid and nonassessable.

 

    	15

    	 

    

 

(e)          No
Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated hereby will not (i) result in a violation of the Articles of Incorporation, any certificate
of designations of any outstanding series of preferred stock of the Company or the By-laws or (ii) violate or conflict with, or
result in a breach of any provision of, or constitute a default (or an event which with notice or lapse of time or both would become
a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture
or instrument to which the Company is a party, or result in a violation of any law, rule, regulation, order, judgment or decree
(including federal and state securities laws and regulations and the rules and regulations of the OTC Bulletin Board (the “OTCBB”)
on which the Common Stock is quoted) applicable to the Company or by which any property or asset of the Company is bound or affected
except for those which could not reasonably be expected to have a material adverse effect on the assets, business, condition (financial
or otherwise), results of operations or future prospects of the Company (a “Material Adverse Effect”). Except those
which could not reasonably be expected to have a Material Adverse Effect, the Company is not in violation of any term of or in
default under its Articles of Incorporation or By-laws. Except as set forth on Schedule 3(c) and except for those which could not
reasonably be expected to have a Material Adverse Effect, the Company is not in violation of any term of or in default under any
material contract, agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or order or any statute, rule or
regulation applicable to the Company. The business of the Company is not being conducted, and
shall not be conducted in violation of any material law, ordinance, or regulation of any governmental entity. Except as specifically
contemplated by this Agreement and as required under the Securities Act and any applicable state securities laws, the Company is
not required to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental
agency in order for it to execute, deliver or perform any of its obligations under or contemplated by this Agreement or the Escrow
Agreement in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and registrations which
the Company is required to obtain pursuant to the preceding sentence have been obtained or effected on or prior to the date hereof.
The Company is unaware of any facts or circumstance, which might give rise to any of the foregoing.

 

(f)          SEC
Filings; Financial Statements. The Company has filed (and, except for certain Current Reports on Form 8-K, has, within the
past two years, timely filed (subject to 12b-25 filings with respect to certain periodic filings)) all reports, schedules, forms,
statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) (all of the foregoing and all other documents filed with the
SEC prior to the date hereof and all exhibits included therein and financial statements and schedules thereto and documents incorporated
by reference therein, being hereinafter referred to herein as the “SEC Filings”).
The SEC Filings are available to the Buyers via the SEC’s EDGAR system. As of their respective dates, the SEC Filings complied
in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC promulgated thereunder,
and none of the SEC Filings, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. As of their respective dates, the audited financial statements of the Company included
in the Company’s SEC Filings for the period from inception on July 9, 2007, to September 30, 2011, and the subsequent unaudited
interim financial statements included in the Company’s SEC Filings (collectively, the “Financial Statements”)
complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of
the SEC with respect thereto. Such financial statements were prepared in accordance with generally accepted accounting principles,
consistently applied, during the periods involved (except (i) as may be otherwise indicated in such Financial Statements or the
notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed
or summary statements), and fairly present in all material respects the financial position of the Company as of the dates thereof
and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments). As of the date hereof, there are no outstanding or unresolved comments in comment letters received
from the staff of the SEC with respect to any of the SEC Filings. No other information provided by or on behalf of the Company
to the Buyer including, without limitation, information referred to in this Agreement, contains any untrue statement of a material
fact or omits to state any material fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading.

 

    	16

    	 

    

 

(g)          Absence
of Litigation. Except as set forth in the Company’s SEC filings, there is no action, suit, proceeding, inquiry or investigation
before or by any court, public board, government agency, self-regulatory organization or body pending against or affecting the
Company or the Common Stock, wherein an unfavorable decision, ruling or finding would (i) adversely affect the validity or enforceability
of, or the authority or ability of the Company to perform its obligations under, this Agreement or any of the documents contemplated
herein, or (ii) have a Material Adverse Effect.

 

(h)          Acknowledgment
Regarding Buyer’s Purchase of the Units. The Company acknowledges and agrees that each Buyer is acting solely in the
capacity of an arm’s length purchaser with respect to this Agreement and the transactions contemplated hereby. The Company
further acknowledges that each Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to this Agreement and the transactions contemplated hereby and any advice given by such Buyer or any of their respective
representatives or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental to such
Buyer’s purchase of the Unit and the underlying securities. The Company further represents to the Buyers that the Company’s
decision to enter into this Agreement has been based solely on the independent evaluation by the Company and its representatives.

 

(i)          No
General Solicitation. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has engaged
in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or
sale of the Units and the underlying securities.

 

(j)          No
Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would
require registration of the Units, including the underlying securities, under the Securities Act or cause this offering of the
Units to be integrated with prior offerings by the Company for purposes of the Securities Act.

 

    	17

    	 

    

 

(k)         Employee
Relations. The Company is not involved in any labor dispute nor, to the knowledge of the Company, is any such dispute threatened.
The Company has no employees.

 

(l)          Intellectual
Property Rights. The Company has no proprietary intellectual property. The Company has not received any notice of infringement
of, or conflict with, the asserted rights of others with respect to any intellectual property that it utilizes.

 

(m)         Environmental
Laws.

 

(i)          The
Company has complied with all applicable Environmental Laws (as defined below), except for violations of Environmental Laws that,
individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect. There is
no pending or, to the knowledge of the Company, threatened civil or criminal litigation, written notice of violation, formal administrative
proceeding, or investigation, inquiry or information request, relating to any Environmental Law involving the Company, except for
litigation, notices of violations, formal administrative proceedings or investigations, inquiries or information requests that,
individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect. For purposes
of this Agreement, “Environmental Law” means any federal, state or local law, statute, rule or regulation or the common
law relating to the environment or occupational health and safety, including without limitation any statute, regulation, administrative
decision or order pertaining to (i) treatment, storage, disposal, generation and transportation of industrial, toxic or hazardous
materials or substances or solid or hazardous waste; (ii) air, water and noise pollution; (iii) groundwater and soil contamination;
(iv) the release or threatened release into the environment of industrial, toxic or hazardous materials or substances, or solid
or hazardous waste, including without limitation emissions, discharges, injections, spills, escapes or dumping of pollutants, contaminants
or chemicals; (v) the protection of wild life, marine life and wetlands, including without limitation all endangered and threatened
species; (vi) storage tanks, vessels, containers, abandoned or discarded barrels, and other closed receptacles; (vii) health and
safety of employees and other persons; and (viii) manufacturing, processing, using, distributing, treating, storing, disposing,
transporting or handling of materials regulated under any law as pollutants, contaminants, toxic or hazardous materials or substances
or oil or petroleum products or solid or hazardous waste. As used above, the terms “release” and “environment”
shall have the meaning set forth in the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended
(“CERCLA”).

 

(ii)         To
the knowledge of the Company there is no material environmental liability with respect to any solid or hazardous waste transporter
or treatment, storage or disposal facility that has been used by the Company.

 

(iii)        The
Company (i) has received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct
its business and (ii) is in compliance with all terms and conditions of any such permit, license or approval.

 

    	18

    	 

    

 

(n)          Title.
The Company does not own or lease any real or personal property.

 

(o)          Internal
Accounting Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance
that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles
and to maintain asset accountability, and (iii) the recorded amounts for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.

 

(p)          No
Material Adverse Breaches, etc. Except as set forth in the SEC Filings, the Company is not subject to any charter, corporate
or other legal restriction, or any judgment, decree, order, rule or regulation which in the judgment of the Company’s officers
has or is expected in the future to have a Material Adverse Effect. Except as set forth in the SEC Filings, the Company is not
in breach of any contract or agreement which breach, in the judgment of the Company’s officers, has or is expected to have
a Material Adverse Effect.

 

(q)          Tax
Status. The Company has made and filed all federal and state income and all other tax returns, reports and declarations required
by any jurisdiction to which it is subject and (unless and only to the extent that the Company has set aside on its books provisions
reasonably adequate for the payment of all unpaid and unreported taxes) has paid all taxes and other governmental assessments and
charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being
contested in good faith and has set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent
to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to
be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim.

 

(r)          Certain
Transactions. Except as set forth in the SEC Filings, and except for arm’s length transactions pursuant to which the
Company makes payments in the ordinary course of business upon terms no less favorable than the Company could obtain from third
parties, none of the officers, directors, or employees of the Company is presently a party to any transaction with the Company
(other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing
for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the Company, any corporation, partnership, trust or other
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner.

 

(s)          Rights
of First Refusal. The Company is not obligated to offer the securities offered hereunder on a right of first refusal basis
or otherwise to any third parties including, but not limited to, current or former stockholders of the Company, underwriters, brokers,
agents or other third parties.

 

(t)          Reliance.
The Company acknowledges that the Buyers are relying on the representations and warranties made by the Company hereunder and that
such representations and warranties are a material inducement to the Buyer purchasing the Units. The Company further acknowledges
that without such representations and warranties of the Company made hereunder, the Buyers would not enter into this Agreement.

 

    	19

    	 

    

 

(u)          Brokers’
Fees. The Company does not have any liability or obligation to pay any fees or commissions to any broker, finder or agent with
respect to the transactions contemplated by this Agreement, except for the payment of the Brokers’ Fees to the Brokers, as
described above.

 

4.           COVENANTS.

 

(a)          Best
Efforts. Each party shall use its best efforts timely to satisfy each of the conditions to be satisfied by it as provided in
Sections 5 and 6 of this Agreement.

 

(b)          Form
D. The Company agrees to file a Form D with respect to the offer and sale of the Units as required under Regulation D. The
Company shall, on or before the Closing Date, take such action as the Company shall reasonably determine is necessary to qualify
the Units, including the PPO Warrants (and the Common Stock underlying the Units and PPO Warrants), or obtain an exemption for
the Units, including the PPO Warrants (and the Common Stock underlying the Units and the PPO Warrants)
for sale to the Buyers at the Closing pursuant to this Agreement under applicable securities or “Blue Sky” laws of
the states of the United States, and shall provide evidence of any such action so taken to the Buyers on or prior to the Closing
Date.

 

(c)          Reporting
Status. Until the date on which the Buyer(s) shall have sold all the Common Stock, including the
Common Stock underlying the Units and PPO Warrants, the Company shall file in a timely manner (or, with respect to Form
8-K reports, shall use its reasonable commercial efforts to file in a timely manner) all reports required to be filed with the
SEC pursuant to the Exchange Act, and the regulations of the SEC thereunder, and the Company shall not terminate its status as
an issuer required to file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would
otherwise permit such termination.

 

(d)          Use
of Proceeds. The Company shall use 100% of the net proceeds from the sale of the Units (after deducting Brokers’ Fees,
legal and accounting fees and expenses and fees payable to the Escrow Agent) for general working capital purposes.

 

(e)          Company
Notes. In conjunction with the closing of the Merger and the Minimum PPO, the Company Notes referenced in Schedule 3(c) hereof,
will either be cancelled or will be spun off to the Split-Off Subsidiary in the Split-Off.

 

(f)          Listings
or Quotation. The Company shall use its best efforts to maintain the listing or quotation of its Common Stock upon the OTC
Bulletin Board.

 

(g)          Corporate
Existence. For a period of two years from the date of the Merger, the Company shall not directly or indirectly consummate any
merger, reorganization, restructuring, reverse stock split, consolidation, sale of all or substantially all of the Company’s
assets, enter into a change of control transaction, or any similar transaction or related transactions (each such transaction,
an “Organizational Change”), unless, prior to the consummation of an Organizational Change, the Company obtains the
written consent of the Buyers then owning a majority of the Units sold in the PPO. In any such case, the Company will make appropriate
provision with respect to such holders’ rights and interests to insure that the provisions of this Section 4(g) will thereafter
be applicable to the Units (including the underlying securities). The provisions of this Section 4(g) shall be inapplicable with
respect to any Organizational Change, including the Name Change, the Split-Off, and the PPO, if any, effected in connection with
the Merger.

 

    	20

    	 

    

 

(h)          Resales
Absent Effective Registration Statement. Each of the Buyers understands and acknowledges that (i) this Agreement and the agreements
contemplated hereby may require the Company to issue and deliver the Common Stock, including the Common
Stock underlying the Units and the PPO Warrants to the Buyers with legends restricting their transferability under the Securities
Act, and (ii) it is aware that resales of such Common Stock, including the Common Stock underlying the
Units and PPO Warrants may not be made unless, at the time of resale, there is an effective registration statement under
the Securities Act covering such Buyer’s resale(s) or an applicable exemption from registration.

 

(i)          [RESERVED]

 

(j)          Disclosure
of Information in Form 8-K.  The Company will disclose in a Form 8-K filed with the SEC within 4 business days of closing
the Merger (or business combination if such transaction assumes a different corporate form) all of the confidential information
provided to Buyers as described in Section 2(u) of this Agreement so that Buyers will not be privy to any confidential information
not made generally available to the public (it being understood that information not disclosed in the Form 8-K filing will no longer
be deemed material non-public information under Regulation FD).

 

5.           CONDITIONS
TO THE COMPANY’S OBLIGATION TO SELL.

 

The obligation of the
Company hereunder to issue and sell the Units to the Buyer(s) at the Closing is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions, provided that these conditions are for the Company’s sole benefit and may be waived
by the Company at any time in its sole discretion:

 

(a)          Each
Buyer shall have executed this Agreement and completed and executed the Investor Certification and the Investor Profile and delivered
them to the Company.

 

(b)          The
Buyer(s) shall have delivered to the Escrow Agent the Purchase Price for Units in respective amounts as set forth on the signature
page(s) affixed hereto and the Escrow Agent shall have delivered the net proceeds to the Company by wire transfer of immediately
available U.S. funds pursuant to the wire instructions provided by the Company.

 

(c)          The
representations and warranties of the Buyer(s) contained in this Agreement shall be true and correct in all material respects as
of the date when made and as of the Closing Date as though made at that time (except for representations and warranties that speak
as of a specific date), and the Buyer(s) shall have performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Buyer(s) at or prior to
the Closing Date.

 

    	21

    	 

    

 

6.           CONDITIONS
TO THE BUYER’S OBLIGATION TO PURCHASE.

 

(a)          The
obligation of the Buyer(s) hereunder to purchase the Units at the Closing is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions:

 

(i)          The
representations and warranties of the Company contained in this Agreement shall be true and correct in all material respects (except
to the extent that any of such representations and warranties is already qualified as to materiality in Section 3 above, in which
case, such representations and warranties shall be true and correct without further qualification) as of the date when made and
as of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date)
and the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Company
shall have obtained any and all consents, permits, approvals, registrations and waivers necessary or appropriate for consummation
of the purchase and sale of the Units, all of which shall be in full force and effect. The Buyers shall have received a certificate,
executed by the President of the Company, dated as of the Closing Date, to the foregoing effect and as to such other matters as
may be reasonably requested by the Buyers, including, without limitation, an update as of the Closing Date regarding the representation
contained in Section 3(c) above.

 

(ii)         The
Company shall have delivered to the Buyers a certificate, executed on behalf of the Company by its Secretary, dated as of the Closing
Date, certifying the resolutions adopted by the Board of Directors of the Company approving the transactions contemplated by this
Agreement and the issuance of the Units, including the PPO Warrants and the Common Stock underlying the Units and PPO Warrants,
certifying the current versions of the Articles of Incorporation and By-laws of the Company and certifying as to the signatures
and authority of persons signing this Agreement on behalf of the Company. The foregoing certificate shall only be required to be
delivered on the first Closing Date, unless any information contained in the certificate has changed.

 

(iii)        The
Buyer(s) shall have received opinions from the Company’s and BLB’s legal counsels, dated as of the Closing Date.

 

(b)          Indemnification
of Buyers. In consideration of the Buyer’s execution and delivery of this Agreement and acquiring the Units, including
the PPO Warrants (and the Common Stock underlying the Units and PPO Warrants) hereunder, and in addition to all of the Company’s
other obligations under this Agreement, the Company shall defend, protect, indemnify and hold harmless the Buyer(s) and each other
holder of the Units (and the Common Stock, including the Common Stock underlying the Units and PPO Warrants), and all of their
officers, directors, employees and agents (including, without limitation, those retained in connection with the transactions
contemplated by this Agreement) (collectively, the “Buyer Indemnitees”) from and against any and all actions, causes
of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith (irrespective
of whether any such Buyer Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable
attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred by the Buyer Indemnitees or any of
them as a result of, or arising out of, or relating to (a) any material breach of any covenant, agreement or obligation of the
Company contained in this Agreement, or (b) any cause of action, suit or claim brought or made against such Buyer Indemnitee and
arising out of or resulting from the execution, delivery, performance or enforcement of this Agreement by any of the Buyer Indemnitees.
To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum
contribution to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under applicable law.

 

    	22

    	 

    

 

7.           [RESERVED]

 

8.           CONFLICT
WAIVER.

 

The Buyers acknowledge
that Adam S. Gottbetter is the owner of Gottbetter & Partners, LLP, counsel to the Company, and Gottbetter Capital Markets,
LLC (the “Placement Agent”) and that Adam S. Gottbetter beneficially owns shares in the Company. The Buyers agree that
in the event of any dispute arising in connection with this Agreement, or otherwise in connection with any transaction or agreement
contemplated and referred herein, Gottbetter & Partners, LLP shall be permitted to continue to represent the Company, and the
Buyers will not seek to disqualify such counsel and waive any objection the Buyers might have with respect to the acting as the
counsel to the Company pursuant to this Agreement.

 

9.           GOVERNING
LAW: MISCELLANEOUS.

 

(a)          Governing
Law. This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York without regard
to the principles of conflict of laws. The parties further agree that any action between them shall be heard exclusively in federal
or state court sitting in the New York County, New York, and expressly consent to the jurisdiction and venue of the Supreme Court
of New York, sitting in New York County and the United States District Court for the Southern District of New York for the adjudication
of any civil action asserted pursuant to this paragraph.

 

(b)          Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event any
signature page is delivered by facsimile transmission, the party using such means of delivery shall cause four (4) additional original
executed signature pages to be physically delivered to the other party within five (5) days of the execution and delivery hereof.

 

(c)          Headings.
The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this
Agreement.

 

(d)          Severability.
If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall
not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability
of any provision of this Agreement in any other jurisdiction.

 

    	23

    	 

    

 

(e)          Entire
Agreement, Amendments. This Agreement supersedes all other prior oral or written agreements between the Buyer(s), the Company,
their affiliates and persons acting on their behalf with respect to the matters discussed herein (including any term sheet), and
this Agreement and the instruments referenced herein contain the entire understanding of the parties with respect to the matters
covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor any Buyer makes any
representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be waived or
amended other than by an instrument in writing signed by the party to be charged with enforcement.

 

(f)          Notices.
Any notices, consents, waivers, or other communications required or permitted to be given under the terms of this Agreement must
be in writing and will be deemed to have been delivered (i) upon receipt, when delivered personally; (ii) upon confirmation of
receipt, when sent by facsimile; (iii) upon receipt when sent by U.S. certified mail, return receipt requested, or (iv) one (1)
day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive
the same. The addresses and facsimile numbers for such communications shall be:

 

	If to the Company, to:	Boldface Group, Inc.
	 	
        50 Brompton Road, Apt. 1X

        Great Neck, NY 11021

	 	Attention:    Noah Levinson, Chief Executive Officer
	 	Facsimile:
	 	 
	With a copy to:	Gottbetter & Partners, LLP
	 	488 Madison Avenue, 12th Floor
	 	New York, New York  10022
	 	Attention:    Adam S. Gottbetter, Esq.
	 	Telephone:  (212) 400-6900
	 	Facsimile:   (212) 400-6901

 

If to the Buyer(s),
to its address and facsimile number set forth on the Buyer Omnibus Signature Page affixed hereto. Each party shall provide five
(5) days’ prior written notice to the other party of any change in address or facsimile number.

 

(g)          Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and
assigns. No party shall assign this Agreement or any rights or obligations hereunder without the prior written consent of the other
party hereto.

 

(h)          No
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

(i)          Survival.
Unless this Agreement is terminated under Section 9(l), the representations and warranties of the Company and the Buyer(s) contained
in Sections 2 and 3, the agreements and covenants set forth in Sections 4, 5 and 9, and the indemnification provisions set forth
in Section 6, shall survive the Closing for a period of two (2) years. The Buyer(s) shall be responsible only for its own representations,
warranties, agreements and covenants hereunder.

 

    	24

    	 

    

 

(j)          Publicity.
The Company shall have the right to approve, before issuance any press release or any other public statement with respect to the
transactions contemplated hereby made by any other party; and the Company shall be entitled, without the prior approval of any
Buyer, to issue any press release or other public disclosure with respect to such transactions required under applicable securities
or other laws or regulations or as it otherwise deems appropriate.

 

(k)          Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

(l)          Termination.
Subject to the prior termination at the discretion of the Company and the Placement Agent, in the event the Closing shall not have
occurred on or before five (5) business days from the end of the Offering Period, the Offering shall not be completed and the Company
shall arrange for the prompt return of all subscription proceeds without interest or deduction.

 

(m)          No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

(n)          Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Buyer
and the Company will be entitled to specific performance under this Agreement. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby
agree to waive in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.

 

(o)          ANTI
MONEY LAUNDERING REQUIREMENTS

 

	The USA PATRIOT Act	 	What is money
 laundering?	 	How big is the problem
 and why is it important?
	
         

        The USA PATRIOT Act is designed to detect, deter, and punish
        terrorists in the United States and abroad. The Act imposes new anti-money laundering requirements on brokerage firms and financial
        institutions. Since April 24, 2002, all brokerage firms have been required to have new, comprehensive anti-money laundering programs.

         

        To help you understand these efforts, we want to provide you
        with some information about money laundering and our steps to implement the USA PATRIOT Act.
	 	
         

        Money laundering is the process of disguising illegally obtained
        money so that the funds appear to come from legitimate sources or activities. Money laundering occurs in connection with a wide
        variety of crimes, including illegal arms sales, drug trafficking, robbery, fraud, racketeering, and terrorism.
	 	
         

        The use of the U.S. financial system by criminals to facilitate
        terrorism or other crimes could well taint our financial markets. According to the U.S. State Department, one recent estimate puts
        the amount of worldwide money laundering activity at $1 trillion a year.

 

    	25

    	 

    

 

	What are we required to do to eliminate money laundering?
	
         

        Under new rules required by the USA PATRIOT Act, our anti-money
        laundering program must designate a special compliance officer, set up employee training, conduct independent audits, and establish
        policies and procedures to detect and report suspicious transaction and ensure compliance with the new laws.
	 	
         

        As part of our required program, we may ask you to provide various
        identification documents or other information. Until you provide the information or documents we need, we may not be able to effect
        any transactions for you.

 

(p)          Omnibus
Signature Page. This Agreement is intended to be read and construed in conjunction with the Registration Rights Agreement.
Accordingly, pursuant to the terms and conditions of this Agreement and such related agreements, it is hereby agreed that the execution
by the Buyer of this Agreement, in the place set forth on the Buyer Omnibus Signature Page below, shall constitute agreement to
be bound by the terms and conditions hereof and the terms and conditions of the Registration Rights Agreement, with the same effect
as if each of such separate but related agreement were separately signed.

 

[REMAINDER
PAGE INTENTIONALLY LEFT BLANK]

 

    	26

    	 

    

 

IN WITNESS WHEREOF,
the Buyers and the Company have caused this Securities Purchase Agreement to be duly executed as of the date first written above.

 

	 	COMPANY:
	 	BOLDFACE Group, Inc.
	 	 
	 	By:	 
	 	Name:
	 	Title:

 

	 	
        BUYERS:

         

        The Buyers executing the Buyer Omnibus
        Signature Page in the form attached hereto as Annex A and delivering the same to the Company or its agents shall be deemed
        to have executed this Agreement and agreed to the terms hereof.

 

    	 

    	 

    

 

To subscribe for Units in the private
offering of BOLDFACE Group, Inc.:

 

		1.	Date and Fill in the amount of Units being purchased and Complete and Sign (i) the
Buyer Omnibus Signature Page of the Securities Purchase Agreement, attached as Annex A-1, and (ii) Amendment to Securities
Purchase Agreement, attached as Annex A-2.

 

		2.	Initial the Investor Certification attached as Annex B.

 

		3.	Complete and Sign the Investor Profile attached as Annex C.

 

		4.	Complete and Sign the Anti-Money Laundering Information Form attached as Annex D.

 

		5.	Fax or email all forms and then send all signed original documents to:

 

Gottbetter & Partners, LLP

488 Madison Avenue, 12th
Floor

New York, NY 10022

Facsimile Number: 212.400.6901

Telephone Number: 212.400.6900

Attention: Kathleen L. Rush

Email: klr@gottbetter.com

 

		6.	If you are paying the Purchase Price by check, a check for the exact dollar amount of the
Purchase Price for the amount of Units you are offering to purchase should be made payable to the order of “CSC Trust Company
of Delaware, as Escrow Agent for BOLDFACE Group, Inc.” and should be sent to CSC Trust Company of Delaware, 2711 Centerville
Road, One little Falls Centre, Wilmington, DE 19808, Attention: Alan R. Halpern.

 

		7.	If you are paying the Purchase Price by wire transfer, you should send a wire transfer for
the exact dollar amount of the Purchase Price of the Units you are offering to purchase according to the following instructions:

 

	Bank Name:	PNC Bank
		300 Delaware Avenue 
		Wilmington, DE 19899 
	ABA Routing Number:	031100089
	Account Name:	CSC Trust Company of Delaware
	Account Number:	5605012373
	Reference:	BOLDFACE Group, Inc.; 79-1743; [insert Purchaser’s name]
	Escrow Agent Contact:	Alan R. Halpern

 

 

    	 

    	 

    

 

ANNEX A-1

 

Buyer
Omnibus Signature Page

to

Securities Purchase Agreement and

Registration Rights Agreement

 

The undersigned, desiring to: (i) enter
into the Securities Purchase Agreement, dated as of _______________1, 2012 (the “Securities Purchase Agreement”),
between the undersigned, BOLDFACE Group, Inc., a Nevada corporation (the “Company”),
and the other parties thereto, in or substantially in the form furnished to the undersigned, (ii) enter into the Registration
Rights Agreement (the “Registration Rights Agreement”), between the undersigned,
the Company, and the other parties thereto, in or substantially in the form furnished
to the undersigned and (iii) purchase the Units of the Company as set forth below, hereby agrees to purchase such Units from the
Company and further agrees to join the Securities Purchase Agreement and the Registration Rights Agreement as a party thereto,
with all the rights and privileges appertaining thereto, and to be bound in all respects by the terms and conditions thereof.
The undersigned specifically acknowledges having read the representations section in the Securities Purchase Agreement entitled
“Buyer’s Representations and Warranties,” and hereby represents that the statements contained therein are complete
and accurate with respect to the undersigned as a Buyer.

 

The Buyer hereby elects to purchase ____________
Units ($____________) (to be completed by the Buyer) under the Securities Purchase Agreement.

 

	BUYER (individual)	 	BUYER (entity)
	 	 	 
	 	 	 
	Signature	 	Name of Entity
	 	 	 
	 	 	 
	Print Name	 	Signature
	 	 	 
	 	 	Print Name:	 
	Signature (if Joint Tenants or Tenants in Common)	 	 
	 	 	Title:	 
	 	 	 
	Address of Principal Residence:	 	Address of Executive Offices:
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	Social Security Number(s):	 	IRS Tax Identification Number: 
	 	 	 
	 	 	 
	Telephone Number:	 	Telephone Number: 
	 	 	 
	 	 	 
	Facsimile Number:	 	Facsimile Number: 
	 	 	 
	 	 	 
	E-mail Address:	 	E-mail Address:
	 	 	 

 

 

1 Will reflect
the Closing Date. Not to be completed by Buyer.  

 

    	 

    	 

    

 

ANNEX A-2

 

AMENDMENT TO

SECURITIES PURCHASE AGREEMENT

 

This Amendment to the
Securities Purchase Agreement (this “Amendment”) is made as of June 28, 2012, by and among BOLDFACE Group, Inc. (formerly
known as Max Cash Media, Inc.), a Nevada corporation (the “Company”), and the Buyer(s) set forth on the signature pages
affixed to the Securities Purchase Agreement (individually, a “Buyer” or collectively, the “Buyers”), and
amends certain provisions of the Securities Purchase Agreement, dated as of June 12, 2012, entered into by and among the Company
and the Buyers (as amended, the “SPA”). Capitalized terms used and not otherwise defined herein have the meanings ascribed
to them in the SPA.

 

THE PARTIES HEREBY AGREE AS FOLLOWS:

 

1.          Reduction
of Minimum PPO Units. The Company and the Buyers hereby amend and restate in its entirety the second Whereas clause of the
SPA to read as follows:

 

“WHEREAS, the parties
desire that, upon the terms and subject to the conditions contained herein, the Company shall sell to the Buyers, as provided herein,
and the Buyers shall purchase in a private placement offering (the “PPO”), a minimum of 8,000,000 units (the “Minimum
PPO”) and a maximum of 20,000,000 units (the “Maximum PPO”) with an additional 3,000,000 units subject to offer
and sale pursuant to an over-allotment option, at a price of $0.25 per unit, with each PPO unit (the “Units”) consisting
of one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and one redeemable
five year common stock purchase warrant of the Company (the “PPO Warrant”) to purchase one share of Common Stock at
a price of $1.00 per share (the “PPO Warrant Shares”); and”

 

2.          Affirmation.
Except to the extent modified hereby, the SPA remains in full force and effect.

 

3.          Counterparts.
This Amendment may be executed in multiple counterparts, each of which may be executed by less than all of the parties and all
of which shall together be deemed to be a single instrument enforceable against the parties. The exchange of copies of this Amendment
and of signature pages by facsimile transmission or in .pdf format shall constitute effective execution and delivery of this Amendment,
and signatures of the parties so transmitted shall be deemed to be original signatures, for all purposes.

 

[Signature Page Follows]

 

    	2

    	 

    

 

ANNEX A-2 

 

IN WITNESS WHEREOF,
the undersigned have executed, or caused to be executed on their behalf by an agent thereunto duly authorized, this Amendment to
the Securities Purchase Agreement as of the date first above written.

 

	 	Company:
	 	 
	 	BOLDFACE GROUP, INC.
	 	 	 
	 	By:	 
	 	 	Name:  Noah Levinson
	 	 	Title:     President

 

	BUYER (individual)	 	BUYER (entity)
	 	 	 	 
	 	 	 	 
	Signature	 	Name of Entity
	 	 	 	 
	 	 	 	 
	Print Name	 	Signature	 
	 	 	 	 
	 	 	Print Name:	 
	Signature (if Joint Tenants or Tenants in Common)	 	 	 
	 	 	Title:	 	 
	 	 	 	 	 

 

    	3

    	 

    

 

ANNEX B

 

BOLDFACE GROUP, INC.

INVESTOR CERTIFICATION

 

For Individual Accredited Investors Only

(all Individual Accredited Investors
must INITIAL where appropriate):

 

	Initial _______	I have a net worth of at least $1 million either individually or through aggregating my individual holdings and those in which I have a joint, community property or other similar shared ownership interest with my spouse. The net value of an individual’s primary residence must be excluded from the calculation of “net worth” for purposes of this calculation.
	Initial _______	I have had an annual gross income for the past two years of at least $200,000 (or $300,000 jointly with my spouse) and expect my income (or joint income, as appropriate) to reach the same level in the current year.
	Initial _______	I am a director or executive officer of Max Cash Media, Inc.

 

For Non-Individual
Accredited Investors

(all Non-Individual
Accredited Investors must INITIAL where appropriate):

 

	Initial _______	The investor certifies that it is a partnership, corporation, limited liability company or business trust that is 100% owned by persons who meet at least one of the criteria for Individual Investors set forth above.
	Initial _______	The investor certifies that it is a partnership, corporation, limited liability company or business trust that has total assets of at least $5 million and was not formed for the purpose of investing the Company.
	Initial _______	The investor certifies that it is an employee benefit plan whose investment decision is made by a plan fiduciary (as defined in ERISA §3(21)) that is a bank, savings and loan association, insurance company or registered investment advisor.
	Initial _______	The investor certifies that it is an employee benefit plan whose total assets exceed $5,000,000 as of the date of this Agreement.
	Initial _______	The undersigned certifies that it is a self-directed employee benefit plan whose investment decisions are made solely by persons who meet at least one of the criteria for Individual Investors.
	Initial _______	The investor certifies that it is a U.S. bank, U.S. savings and loan association or other similar U.S. institution acting in its individual or fiduciary capacity.
	Initial _______	The undersigned certifies that it is a broker-dealer registered pursuant to §15 of the Securities Exchange Act of 1934.
	Initial _______	The investor certifies that it is an organization described in §501(c)(3) of the Internal Revenue Code with total assets exceeding $5,000,000 and not formed for the specific purpose of investing in the Company.
	Initial _______	The investor certifies that it is a trust with total assets of at least $5,000,000, not formed for the specific purpose of investing in the Company, and whose purchase is directed by a person with such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of the prospective investment.
	Initial _______	The investor certifies that it is a plan established and maintained by a state or its political subdivisions, or any agency or instrumentality thereof, for the benefit of its employees, and which has total assets in excess of $5,000,000.
	Initial _______	The investor certifies that it is an insurance company as defined in §2(13) of the Securities Act of 1933, or a registered investment company.

 

 

    	 

    	 

    

 

For Non-U.S.
Person Investors

 

(all Investors who are not a U.S. Person
must INITIAL this section):

 

	Initial _______	The investor is not a “U.S. Person” as defined in Regulation S; and specifically the investor is not:
	 	 
	A.	a natural person resident in the United States of America, including its territories and possessions (“United States”);
	 	 
	B.	a partnership or corporation organized or incorporated under the laws of the United States;
	 	 
	C.	an estate of which any executor or administrator is a U.S. Person;
	 	 
	D.	a trust of which any trustee is a U.S. Person;
	 	 
	E.	an agency or branch of a foreign entity located in the United States;
	 	 
	F.	a non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. Person;
	 	 
	G.	a discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; or
	 	 
	H.	a partnership or corporation: (i) organized or incorporated under the laws of any foreign jurisdiction; and (ii) formed by a U.S. Person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a) under the Securities Act) who are not natural persons, estates or trusts.

 

And, in
addition:

 

	I.	the investor was not offered the securities in the United States;
	 	 
	J.	at the time the buy-order for the securities was originated, the investor was outside the United States; and
	 	 
	K.	the investor is purchasing the securities for its own account and not on behalf of any U.S. Person (as defined in Regulation S) and a sale of the securities has not been pre-arranged with a purchaser in the United States.

 

 

    	 

    	 

    

 

ANNEX C

 

BOLDFACE GROUP, INC.

Investor Profile

 (Must be completed by Investor)

 

Section A - Personal Investor Information

 

	Investor Name(s):	 
	Individual executing Profile or Trustee:	 
	Social Security Numbers / Federal I.D. Number:	 
	Date of Birth:	 	 	 	Marital Status:	 	 
	Joint Party Date of Birth:	 	 	 	Investment Experience (Years):	 	 
	Annual Income:	 	 	 	Liquid Net Worth:	 	 
	Net Worth (excluding value of primary residence):	 
	Tax Bracket:	 	 	15% or below	 	 	25% - 27.5%	 	 	Over 27.5%
	 	 
	Home Street Address:	 
	Home City, State & Zip Code:	 
	Home Phone:	 	  Home Fax:	 	  Home Email:	 
	Employer:	 
	Employer Street Address:	 
	Employer City, State & Zip Code:	 
	Bus. Phone:	 	  Bus. Fax:	 	  Bus. Email:	 
	Type of Business:	 
	(PLACEMENT AGENT) Account Executive / Outside Broker/Dealer:
	 
	If you are a United States citizen,
    please list the number and jurisdiction of issuance of any other government-issued document evidencing residence and bearing
    a photograph or similar safeguard (such as a driver’s license or passport), and provide a photocopy of each of the documents
    you have listed.
	 
	If you are NOT a United States citizen, for each
    jurisdiction of which you are a citizen or in which you work or reside, please list (i) your passport number and country of
    issuance or (ii) alien identification card number AND (iii) number and country of issuance of any other government-issued
    document evidencing nationality or residence and bearing a photograph or similar safeguard, and provide a photocopy of each
    of these documents you have listed.  These photocopies must be certified by a lawyer as to authenticity. 
	 
	 
	Section
    B – Certificate Delivery Instructions
	 
	 	 	Please deliver certificate to the Employer Address listed in Section A.
	 	 	Please deliver certificate to the Home Address listed in Section A.
	 	 	Please deliver certificate to the following address:	 
	 
	Section
    C – Form of Payment – Check or Wire Transfer
	 
	 	 	Check payable to CSC Trust Company of Delaware , as Escrow Agent for BOLDFACE
    Group, Inc.
	 	 	Wire funds from my outside account according to Section 1(a) of the Securities
    Purchase Agreement.
	 	 	The funds for this investment are rolled over, tax deferred from __________
    within the allowed 60 day window.
	 
	Please check if you are a FINRA member or affiliate of a FINRA member firm:
    ________
	 
	 	 	 
	Investor Signature	 	Date
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

 

    	 

    	 

    

 

ANNEX D

 

 

MEMBER: FINRA, SIPC

 

ANTI-MONEY LAUNDERING INFORMATION FORM

The following is required in accordance
with the AML provision of the USA PATRIOT ACT.

 (Please fill out and return with
requested documentation.)

 

	INVESTOR NAME:	 
	 	 
	LEGAL ADDRESS:	 
	 	 
	 	 
	SSN# or TAX ID#	 
	OF INVESTOR:	 

 

FOR INVESTORS WHO ARE INDIVIDUALS: 

 

	YEARLY INCOME:	 	AGE:	 

 

	NET WORTH (excluding value of primary residence):	 

 

	OCCUPATION:	 
	 	 
	ADDRESS OF EMPLOYER:	 
	 	 
	 	 
	 	 
	INVESTMENT OBJECTIVE(S):	 

 

IDENTIFICATION & DOCUMENTATION
AND SOURCE OF FUNDS:

 

		1.	Please submit a copy of non-expired identification for the authorized signatory(ies) on the investment
documents, showing name, date of birth, address and signature. The address shown on the identification document MUST match the
Investor’s address shown on the Investor Signature Page.

 

	Current Driver’s License	or	Valid Passport	or	Identity Card

(Circle one or more)

 

		2.	If the Investor is a corporation, limited liability company, trust or other type of entity, please
submit the following requisite documents: (i) Articles of Incorporation, By-Laws, Certificate of Formation, Operating Agreement,
Trust or other similar documents for the type of entity; and (ii) Corporate Resolution or power of attorney or other similar document
granting authority to signatory(ies) and designating that they are permitted to make the proposed investment.

 

		3.	Please advise where the funds were derived from to make
the proposed investment:

 

	Investments	Savings	Proceeds of Sale	Other ____________

(Circle one or more)

 

	Signature:	 
	 	 
	Print Name:	 
	 	 
	Title (if applicable):	 
	 	 
	Date:	 

 

488 Madison Ave., 12th Fl., New
York, NY 10022-5718

T 212.400.6990      F 212.400.6999

  

    	 

    	 

    

 

EXHIBIT A

 

Form of Escrow Agreement

 

[Exhibit 10.4]

 

    	 

    	 

    

 

EXHIBIT B

 

Form of PPO Warrant

 

[Exhibit 4.1]

 

    	 

    	 

    

 

EXHIBIT C

 

Form of Registration Rights Agreement

 

[Exhibit 10.6]

 

    	 

    	 

    

 

EXHIBIT D

 

Risk Factors

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}]]